Scientific Director, Medical Payer Strategy - Oncology
AbbVie
Summary
The Scientific Director provides medical and scientific input into medical market access payer, group purchasing organizations, health systems, guidelines, and pathways oncology scientific objectives and tactics for healthcare access decision makers.
Job description
Develops and executes medical market access activities such as payer/healthcare access decision maker strategies, educational initiatives (medical education, data, guidelines, pathways, and value proposition), and translates payer/HCMD insights into strategy.
- Works cross functionally in a highly matrixed environment with commercial, HEOR and medical affairs teams to provide strategic payer/HCDM input into brand strategies and shape integrated holistic value evidence plan.
- Leads development of medical affairs payer/HCDM strategy for the assigned therapeutic area and assets, translating the clinical, economic, humanistic, and real-world evidence into a differentiated value narrative that shapes access strategy, brand and portfolio priorities, and enterprise decisions.
- Actively participates in relevant cross functional brand, medical affairs and market access teams to provide medical, scientific, pharmaeconomic, and healthcare landscape input into portfolio and product strategies, influences without authority in a matrixed environment.
- Leads development and approval of medical affairs access/HCDM field and omnichannel materials.
- Leads and delivers training to the Medical Outcomes Science Liaison teams.
- Partners on the development of integrated evidence plan with Medical Affairs, HEOR to support scientific and business strategy aligned to Medical Affairs Evidence Gaps.
- Develops strategy for payer/HCDM collaborative customer research, thought-leadership forums, and external partnerships aligned with therapeutic area and AbbVie objectives in partnership with HEOR and medical affairs.
- Monitors scientific, health economic, access and healthcare policy trends through conferences, insights gathering and external engagement; proactively provides inputs into portfolio, therapeutic area and brand strategies.
- Responsible for compliance with applicable Corporate and Divisional Policies and procedures.
- Responsible for understanding the legal and regulatory requirements as well as the healthcare landscape and accountable for complying with those requirements.
- Serves as the scientific team interface for key regulatory, OEC and Legal discussions.
- May assist with the scientific review, development, execution and communication of medical affairs sponsored or supported RWE research activities.
- Lead cross functional and functional sub teams responsible for discrete projects within the therapeutic area.
Requirements
- Advanced Education PhD, PharmD, PA, NP highly preferred
- Residency or additional post doctorate highly preferred
- Typically 8 years' experience in the pharmaceutical industry or equivalent
- Substantial understanding of managed care required
- Pharmacoeconomic experience preferred
- Management and leadership experience at project level
- Experience with strategic initiatives and issues
- Proven leadership skills in a cross-functional environment
- International experience is a plus
- Ability to interact externally and internally to support global business strategy
- Ability to advance RWE studies or medical affairs directed research independently with little supervision
- Knowledge of statistical methodology
- Knowledge of regulatory requirements governing RWE
- Experience in development strategy and the design of RWE protocols
- Excellent oral and written communication skills
- Works mostly independently with limited guidance
Benefits
- Paid Time Off
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401(k)
- Long-Term Incentive Programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.